Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Codex Genetics logo — Unraveling your uniqueness

Codex Genetics

Unraveling your uniqueness

Founded 2013 Hong Kong S.a.r. Hong Kong S.a.r. 12 employees Seed Total: $41.25K Biotechnology

General Information

Company Name Codex Genetics
Founded Year 2013
Location Hong Kong S.a.r. Hong Kong S.a.r.
Employees 12
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Codex Genetics. To contact Codex Genetics, visit codexgenetics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Codex Genetics compare?

A PDF of Codex Genetics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Codex Genetics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Codex Genetics

Codex Genetics Codex Genetics, founded in 2013 Q1 by scientists specialized in genomics and bioinformatics, aims to personalize cancer treatment through its cutting-edge technology. The company's flagship product, GENESIS, is a cancer genetics test developed using next generation sequencing. Codex's growing pharmacogenomics database provides valuable insights into individual tumor causes, enabling tailored treatment for cancer patients. Their clinical pharmacogenomics platform uses individual genetic information to inform treatment options and predict drug responses. By offering two clinically actionable genetic tests for cancer and other FDA-approved diseases, Codex supports clinicians in providing personalized medication in the realm of "Precision Medicine." The company received a $41.25K Seed Round investment on 01 January 2014 from Cyberport Hong Kong. With its focus on biotechnology, Codex Genetics is headquartered in Hong Kong S.a.r.

Business keywords: genomics, bioinformatics, next generation sequencing, cancer genetics, pharmacogenomics, precision medicine, personalized medication, Asian-specific genetic analysis, Exome sequencing technology, clinical pharmacogenomics platform, medical professionals, precision oncology, cancer treatment, genetic testing, data interpretation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $41.25K 1
Cyberport Hong Kong
01 Jan 2014

Codex Genetics Alternatives & Competitors

View All Alternatives
Codex Genetics vs
ACT Genomics
ACT Genomics Taiwan

Make Personalized Medicine Accessible To All.

Venture round
121 employees
Biotechnology, Health Care
Compare Codex Genetics vs ACT Genomics
Codex Genetics vs
Mendelics
Mendelics Brazil

Análise genômica ao alcance de todos

154 employees
Biotechnology, Health Care
Codex Genetics vs
CENTOGENE
CENTOGENE Germany

Empowering precision medicine through advanced diagnosis 

IPO
475 employees
Biotechnology, Health Care
View all alternatives

FAQ About Codex Genetics

Unraveling your uniqueness
Codex Genetics was founded in 2013.
Codex Genetics is headquartered in Hong Kong S.a.r..
Codex Genetics operates in Biotechnology. Its work centres on genomics, bioinformatics, next generation sequencing and cancer genetics.
Codex Genetics has approximately 12 employees.
Codex Genetics has completed 1 funding round, raising a total of $41.25K. The latest funding stage is Seed.
Top alternatives and competitors to Codex Genetics include ACT Genomics, Mendelics, CENTOGENE, Personal Genome Diagnostics, Agendia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Codex Genetics and ACT Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Codex Genetics, https://bouncewatch.com/company/codex-genetics, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout